Integra LifeSciences Continues to Make Progress on Its ESG Strategy

ESG Report Highlights - Integra LifeSciences issued its latest ESG report, highlighting the company's 2023 ESG performance and ongoing efforts against the ESG strategy and roadmap established three years ago [1] - The company's president and CEO emphasized the importance of innovating treatment pathways to advance patient outcomes and set new standards of care [2] - Integra's ESG report includes highlights in key areas: Environmental, Social, and Governance [2] Environmental Initiatives - Recalculated Scope 1, 2, and 3 emissions and partnered with an external consultant to conduct energy assessments at highest energy usage locations to identify energy reduction opportunities and improve greenhouse gas footprint [2] Social Initiatives - Bolstered diversity and inclusion efforts by adding a new employee resource group [2] - Focused on early-in-career talent by providing support and hands-on experience to diverse college students and graduates [2] Governance Initiatives - Revised Code of Conduct and continued to strengthen anti-bribery and corruption program through ongoing training curriculums and programs [2] Alignment with External Guidelines - Integra prepared its ESG report in alignment with external guidelines and measurement frameworks, including the Global Reporting Index and the Sustainability Accounting Standards Board Index [2] Company Overview - Integra LifeSciences is driven by its purpose of restoring patients' lives and innovates treatment pathways to advance patient outcomes and set new standards of surgical, neurologic, and regenerative care [4] - The company offers a comprehensive portfolio of high quality, leadership brands [4]